Diabetic Cardiomyopathy (CarDiab)

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Diabetic Cardiomyopathies

Study type: Observational

Funder types: Other

Identifiers

NCT04593173

7905 (Other Identifier)

Details and patient eligibility

About

Diabetes represents one of the 10 leading causes of death in the world and concerns 5% of the French population (> 3.3 million patients). About 30% of diabetic patients will develop heart failure. The specific and early identification of diabetic cardiomyopathy at a subclinical stage (asymptomatic patients with normal LVEF) will thus make it possible to predict the risk of the onset of heart failure and to strengthen their monitoring and further adapt their treatment.

Enrollment: 77 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patient (≥18 years old)
• Type 2 diabetic and hypertensive subjects, cardiac asymptomatic, without myocardial ischemia documented by Dobutamine stress ultrasound (ESD), having at least 1 additional CV risk factor among: dyslipidemia, active or stopped smoking for less than 3 years, family history (1st degree relationship) of major CV accident before age 60, obliterating arteriopathy of the lower limbs and / or carotid atheroma, or proteinuria.
• Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

• Patient who expressed his opposition to participating in the study
• Valvular heart disease (moderate to severe valve disease), hypertrophic or dilated (MVGi> 95 g / m2 in women and MVGi> 115 g / m2 in men), chronic pulmonary;
• History of cardiotoxic chemotherapy;
• Subject under legal protection, under guardianship or under guardianship.